cagrilintide pancreatitis Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Cagrilintide–Semaglutide in Adults with Overweight

& Adan, R

TB-500, a synthetic analogue of thymosin beta-4, is a 43-amino acid peptide that was first characterized in the 1960s from bovine thymus tissue and has since been studied for its regenerative effects in wound healing and tissue remodeling

10.1016/S1096-6374(03)00038-8

[ 5 ] The mechanism of action of DSIP, however, remains unclear

Benefits : Reduces intestinal inflammation Promotes gut lining healing Supports healthy microbiome Reduces permeability (leaky gut) Applications : Inflammatory bowel disease (supportive) IBS with inflammation Leaky gut syndrome Post-antibiotic gut damage Protocol : 1-2mg daily oral or subcutaneous, 8-12 weeks Combines with : BPC-157 (excellent gut peptide) Injectable GHK-Cu dosing Most effective route for systemic benefits